Opioid use disorder can involve heroin, fentanyl, oxycodone, codeine, hydromorphone, morphine, tramadol, or other opioid medicines and substances. It is associated with tolerance, physical dependence, craving, loss of control, and continued use despite harm. Because tolerance changes and unregulated supplies can contain unexpected substances, overdose risk may remain high even after a period without use.
THE BALANCE provides private assessment and treatment for selected adults with opioid use disorder when medical risk can be managed responsibly within a voluntary residential pathway. Treatment is not defined by detoxification alone. It requires evidence-based medication options, overdose prevention, psychiatric and psychological care, physical-health assessment, family and environmental work, and continuing treatment after the residential phase.
Opioid Use Disorder, Physical Dependence, and Pain Treatment
Physical dependence can develop during appropriately prescribed opioid treatment and means that abrupt reduction may produce withdrawal. Opioid use disorder involves a broader pattern of impaired control and clinically significant harm. The distinction matters because a person should not be labeled with addiction solely because their body has adapted to prescribed medication.
Assessment considers the original reason for opioid exposure, current pain, dose and duration, nonprescribed use, route, source, attempts to reduce use, functional consequences, and use with alcohol, benzodiazepines, sleeping medication, gabapentinoids, or stimulants.
Overdose Risk Comes First
Opioid overdose can suppress breathing and cause death. Risk increases with fentanyl or an unknown supply, return to use after reduced tolerance, higher doses, injection, previous overdose, concurrent sedatives or alcohol, and medical conditions affecting breathing or metabolism.
The assessment should establish overdose history, current supply, access to naloxone, people who may witness an overdose, and whether urgent medical care is needed. Suspected overdose is an emergency. A private residence is not a substitute for emergency services, ventilation support, or hospital care.
Naloxone and Practical Overdose Prevention
Naloxone can reverse an opioid overdose temporarily and should be considered as part of a practical safety plan for people at risk and those close to them. Availability, formulation, training, and local requirements vary by country.
Providing naloxone does not replace treatment, and treatment does not remove the need for overdose planning. The period after detoxification, hospitalization, incarceration, or residential care can be particularly dangerous if tolerance has fallen and the person returns to a previous dose.
Medication for Opioid Use Disorder
Evidence-based treatment may include buprenorphine, methadone, or extended-release naltrexone, depending on the client, jurisdiction, access, contraindications, prior response, and informed preference. These medicines are not simply substitutions for one addiction. They can reduce illicit opioid use, withdrawal, craving, overdose risk, and mortality when appropriately prescribed and continued.
THE BALANCE does not present medication-free treatment as inherently superior. The responsible prescriber should explain options, benefits, risks, induction requirements, monitoring, interactions, and how treatment will continue after the client leaves the residence.
Why Detoxification Alone Is Not Sufficient
Withdrawal management may be necessary, but completing withdrawal does not by itself treat opioid use disorder. Detoxification without ongoing medication or another evidence-based treatment plan can increase the risk of return to use and overdose because tolerance falls while triggers and craving remain.
If the client requests a medication-free approach, the team should discuss the evidence and risks without coercion. Informed choice requires an accurate explanation of alternatives, not a promise that comfort, privacy, or willpower can replace ongoing treatment.
Withdrawal and Medical Stabilization
Opioid withdrawal can involve anxiety, agitation, muscle and bone pain, gastrointestinal symptoms, sweating, insomnia, and intense craving. It is often profoundly distressing and can create dehydration, relapse, or other complications. Co-occurring alcohol, benzodiazepine, or sedative withdrawal may be medically dangerous.
Medical Stabilization and Detox begins with an assessment of substances, timing, dose, physical health, pregnancy where relevant, medication, previous withdrawal, overdose, and psychiatric risk. Hospital or specialist care may be required before or during the treatment pathway.
Psychiatric and Psychological Assessment
Depression, anxiety, trauma, grief, ADHD symptoms, sleep problems, and suicidal thinking may precede opioid use, result from it, or become intertwined with withdrawal and chronic pain. The team considers diagnostic timing rather than assigning every symptom to one cause.
Psychological treatment may address triggers, craving, shame, loss, relationships, behavior, coping, trauma where relevant, and rebuilding a life that does not depend on opioid use. It should complement—not replace—appropriate medication and medical care.
Chronic Pain and Opioid Use Disorder
Some clients continue to experience significant pain. Treatment should not frame all pain as psychological or remove analgesia without a credible alternative. Pain medicine, addiction medicine, psychiatry, physical health, function, sleep, and emotional well-being may need coordinated review.
The objective is a safer and more sustainable plan. That may include nonopioid medication, physical rehabilitation, behavioral pain strategies, specialist procedures, or continued opioid treatment under clearer governance, depending on the case. THE BALANCE does not replace a specialist pain service.
Polysubstance Use and Prescribing Safety
Opioids combined with benzodiazepines, sleeping medications, alcohol, or other central nervous system depressants can increase respiratory risk. The full medication and substance list must be reconciled, including prescriptions from different clinicians, over-the-counter products, and substances obtained outside medical care.
Medication changes remain the responsibility of an appropriately licensed prescriber. Abrupt discontinuation of benzodiazepines or other dependent-forming medicine can be dangerous and should not occur simply because opioid treatment has begun.
Family, Trust, and Access
Families may have responded to repeated crises, overdoses, financial loss, secrecy, or requests for money. They may hold medication, monitor behavior, or alternate between rescue and confrontation. Treatment can help establish safer roles without making relatives responsible for clinical surveillance.
With consent, selected family members may learn how to respond to overdose, support medication adherence, recognize warning signs, and maintain boundaries. A payer or family office does not automatically receive clinical information.
Fully Private Residential Treatment
THE BALANCE provides one-client residential treatment in Mallorca and Zurich. The model allows appointments, medication administration, rest, meals, psychological work, family contact, and practical support to be coordinated around one client.
Privacy may be important for executives, public figures, and members of prominent families, but it cannot override safety. Medication for opioid use disorder, hospital transfer, toxicology, external specialist care, or emergency response may involve independent providers and records.
Continuing Care and Medication Continuity
Before discharge, the plan identifies who will prescribe and monitor medication, where it can be dispensed, what happens during international travel, which local clinicians will remain involved, and how urgent concerns will be handled. Cross-border prescribing cannot be assumed.
International Continuing Care may include addiction medicine, psychiatry, psychotherapy, recovery support, family work, overdose prevention, and a clear response to missed medication, craving, or return to use.
Suitability and Hospital Boundaries
Immediate overdose, severe intoxication, unstable respiratory or medical status, serious infection, uncontrolled withdrawal from several substances, acute psychosis, or immediate suicide risk requires an appropriate hospital or emergency pathway. A private residence is not an acute medical ward, secure unit, or involuntary setting.
Admission depends on voluntary participation, travel fitness, current risk, medication access, available prescribers, hospital pathways, and the feasibility of continuing evidence-based treatment after discharge. See Suitability and Entry Criteria.
Mallorca, Zurich, and London
Residential care is provided in Mallorca and Zurich. The selected location depends on medical needs, prescribing pathways, privacy, travel, existing care, and availability.
London may support selected assessment, preparation, transition, and continuing-care coordination. It does not provide residential detoxification or inpatient opioid treatment.
Treatment Retention and Transitions
Starting medication or completing a residential stay is not the same as remaining in effective care. Interruptions in prescribing, travel, missed appointments, stigma, or disagreement among clinicians can create periods of avoidable risk. The treatment plan should therefore consider retention from the beginning.
Transitions require direct communication between responsible professionals, confirmation of the next prescription or appointment, and a plan for delays. A client should not leave the residence with only a recommendation to “find someone locally” when medication continuity is clinically necessary.
Infections and Wider Physical Health
Depending on route and history, assessment may include skin and soft-tissue infection, hepatitis, HIV, endocarditis risk, respiratory disease, dental health, constipation, endocrine effects, and other consequences. Testing and treatment are based on consent, indication, and appropriate independent medical care.
Physical-health needs should not be treated as secondary to addiction. They can affect medication choice, travel fitness, psychiatric symptoms, and the appropriate treatment setting.
Stigma and Language
Terms such as “addict,” “clean,” or “failed treatment” can increase shame and obscure clinical information. THE BALANCE uses person-centered language and considers return to use as a signal for reassessment, not a moral verdict.
Respectful language does not minimize risk. Opioid use disorder is associated with potentially fatal overdose, and the treatment plan must remain direct about medication, safety, and continuing care.
Recovery Support and Personal Choice
Peer recovery groups, mutual-aid communities, individual recovery coaching, and other support systems may help some people sustain change. No single philosophy is required for every client, and medication for opioid use disorder should not be treated as incompatible with recovery.
The continuing plan reflects the client’s values while remaining honest about overdose risk and the evidence for treatment. Support should increase independence and connection rather than create shame or dependence on one institution.
